Puente XS, Jares P, Campo E (2018) Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood 131(21):2283–2296. https://doi.org/10.1182/blood-2017-10-764373

Article  CAS  PubMed  Google Scholar 

Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140(11):1229–1253. https://doi.org/10.1182/blood.2022015851

Article  CAS  PubMed  Google Scholar 

Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G et al (2004) Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 103(6):2337–2342. https://doi.org/10.1182/blood-2003-09-3277

Article  CAS  PubMed  Google Scholar 

Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA et al (2002) Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 100(2):635–639. https://doi.org/10.1182/blood.v100.2.635

Article  CAS  PubMed  Google Scholar 

Rawstron AC, Bennett FL, O’Connor SJ, Kwok M, Fenton JA, Plummer M et al (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359(6):575–583. https://doi.org/10.1056/NEJMoa075290

Article  CAS  PubMed  Google Scholar 

Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al (2010) Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 78(Suppl 1):S19-23. https://doi.org/10.1002/cyto.b.20533

Article  PubMed  PubMed Central  Google Scholar 

Strati P, Shanafelt TD (2015) Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 126(4):454–462. https://doi.org/10.1182/blood-2015-02-585059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agathangelidis A, Ljungstrom V, Scarfo L, Fazi C, Gounari M, Pandzic T et al (2018) Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations. Haematologica 103(5):865–873. https://doi.org/10.3324/haematol.2017.177212

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habermehl GK, Durkin L, Hsi ED (2021) A tissue counterpart to monoclonal B-cell lymphocytosis. Arch Pathol Lab Med 145(12):1544–1551. https://doi.org/10.5858/arpa.2020-0654-OA

Article  PubMed  Google Scholar 

Gibson SE, Swerdlow SH, Ferry JA, Surti U, Dal Cin P, Harris NL et al (2011) Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 96(8):1144–1152. https://doi.org/10.3324/haematol.2011.042333

Article  PubMed  PubMed Central  Google Scholar 

Hallek M, Al-Sawaf O (2021) Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol 96(12):1679–1705. https://doi.org/10.1002/ajh.26367

Article  PubMed  Google Scholar 

Cross M, Dearden C (2019) B and T cell prolymphocytic leukaemia. Best Pract Res Clin Haematol 32(3):217–228. https://doi.org/10.1016/j.beha.2019.06.001

Article  CAS  PubMed  Google Scholar 

Rawstron AC, Kreuzer KA, Soosapilla A, Spacek M, Stehlikova O, Gambell P et al (2018) Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry B Clin Cytom 94(1):121–128. https://doi.org/10.1002/cyto.b.21595

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D et al (2010) Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95(9):1526–1533. https://doi.org/10.3324/haematol.2010.022277

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gradowski JF, Sargent RL, Craig FE, Cieply K, Fuhrer K, Sherer C et al (2012) Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression. Am J Clin Pathol 138(1):132–139. https://doi.org/10.1309/AJCPIVKZRMPF93ET

Article  PubMed  Google Scholar 

Patel N, Durkin L, Bodo J, Hsi ED (2020) Immunohistochemical expression of lymphoid enhancer binding factor 1 in CD5-positive marginal zone, lymphoplasmacytic, and follicular lymphomas. Am J Clin Pathol 153(5):646–655. https://doi.org/10.1093/ajcp/aqz207

Article  CAS  PubMed  Google Scholar 

Baliakas P, Jeromin S, Iskas M, Puiggros A, Plevova K, Nguyen-Khac F et al (2019) Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood 133(11):1205–1216. https://doi.org/10.1182/blood-2018-09-873083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramos-Campoy S, Puiggros A, Bea S, Bougeon S, Larrayoz MJ, Costa D et al (2022) Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients. Haematologica 107(3):593–603. https://doi.org/10.3324/haematol.2020.274456

Article  CAS  PubMed  Google Scholar 

International CLLIPIwg (2016) An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol 17(6):779–790. https://doi.org/10.1016/S1470-2045(16)30029-8

Article  Google Scholar 

Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T, Tresoldi C, Davis Z, Giudicelli V et al (2022) Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL. Leukemia. https://doi.org/10.1038/s41375-022-01604-2

Article  PubMed  PubMed Central  Google Scholar 

Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martin S et al (2021) IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics. Blood 137(21):2935–2946. https://doi.org/10.1182/blood.2020008311

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343(26):1910–1916. https://doi.org/10.1056/NEJM200012283432602

Article  CAS  PubMed  Google Scholar 

O’Brien S, Jones JA, Coutre SE, Mato AR, Hillmen P, Tam C et al (2016) Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study. Lancet Oncol 17(10):1409–1418. https://doi.org/10.1016/S1470-2045(16)30212-1

Article  CAS  PubMed  Google Scholar 

Stilgenbauer S, Eichhorst B, Schetelig J, Coutre S, Seymour JF, Munir T et al (2016) Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol 17(6):768–778. https://doi.org/10.1016/S1470-2045(16)30019-5

Article  CAS  PubMed  Google Scholar 

Nadeu F, Delgado J, Royo C, Baumann T, Stankovic T, Pinyol M et al (2016) Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. Blood 127(17):2122–2130. https://doi.org/10.1182/blood-2015-07-659144

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bomben R, Rossi FM, Vit F, Bittolo T, D’Agaro T, Zucchetto A et al (2021) TP53 mutations with low variant allele frequency predict short survival in chronic lymphocytic leukemia. Clin Cancer Res 27(20):5566–5575. https://doi.org/10.1158/1078-0432.CCR-21-0701

Article  CAS  PubMed  Google Scholar 

Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T et al (2018) ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia 32(5):1070–1080. https://doi.org/10.1038/s41375-017-0007-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J et al (2015) Mutations driving CLL and their evolution in progression and relapse. Nature 526(7574):525–530. https://doi.org/10.1038/nature15395

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puente XS, Bea S, Valdes-Mas R, Villamor N, Gutierrez-Abril J, Martin-Subero JI et al (2015) Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526(7574):519–524. https://doi.org/10.1038/nature14666

Article  CAS  PubMed  Google Scholar 

Lee J, Wang YL (2020) Prognostic and predictive molecular biomarkers in chronic lymphocytic leukemia. J Mol Diagn 22(9):1114–1125. https://doi.org/10.1016/j.jmoldx.2020.06.004

Article  CAS  PubMed  Google Scholar 

Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD (2018) Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis. Ann Hematol 97(10):2005–2008. https://doi.org/10.1007/s00277-018-3350-5

Article  PubMed  Google Scholar 

Parikh SA, Kay NE, Shanafelt TD (2014) How we treat Richter syndrome. Blood 123(11):1647–1657. https://doi.org/10.1182/blood-2013-11-516229

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M et al (2016) Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus statu